Literature DB >> 20012334

Six weeks antibiotic therapy for all bone infections: results of a cohort study.

R Farhad1, P-M Roger, C Albert, C Pélligri, C Touati, P Dellamonica, C Trojani, P Boileau.   

Abstract

There is no consensus on the antibiotic therapy for bone infection due to the heterogeneous spectrum of diseases. Most authors suggest different durations of treatment based on pathophysiological considerations. However, adverse effects are related, at least in part, to the duration of treatment. We, therefore, investigated a 6 weeks antibiotic combination therapy for all cases of bone infection. Herewith, we report the results of this therapeutic approach. This is a cohort study including all patients presenting with bone infection, regardless of the mechanism involved. The diagnosis was based on bone biopsy obtained through invasive procedures. Chronic bone infection was defined as a history of disease of over 1 month duration. The duration of clinical follow-up following treatment discontinuation was at least 6 months. Cured bone infection was defined as the absence of relapse after antibiotic discontinuation. One hundred and eighteen patients were included between July 2005 and March 2009; 61 presented with bone infection following prosthetic implant (52%) and the 57 remaining patients had bone infection without foreign material (48%). Surgery was required for 80 patients (68%). Microbial agents were identified in 116/118 patients, with 24 patients presenting with polymicrobial sepsis (20%). The mean duration of antibiotic treatment was 42 +/- 0.2 days and the mean clinical follow-up was 27 +/- 14 months. The treatment success rate was 91.5% (108/118). Six weeks of antimicrobial therapy appears to be effective for nearly all bone infections, regardless of the pathophysiology. These results encourage us to pursue attempts to simplify the management of bone infection without obvious prejudice to the patient.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20012334     DOI: 10.1007/s10096-009-0842-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  25 in total

Review 1.  The incidence of sepsis after total hip replacement arthroplasty.

Authors:  S Nasser
Journal:  Semin Arthroplasty       Date:  1994-10

Review 2.  Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials?

Authors:  Luca Lazzarini; Benjamin A Lipsky; Jon T Mader
Journal:  Int J Infect Dis       Date:  2005-05       Impact factor: 3.623

3.  Efficacy and safety of vancomycin constant-rate infusion in the treatment of chronic Gram-positive bone and joint infections.

Authors:  E. Bernard; I. Perbost; M. Carles; A. Michiels; H. Carsenti-Etesse; R.M. Chichmanian; B. Dunais; P. Dellamonica
Journal:  Clin Microbiol Infect       Date:  1997-08       Impact factor: 8.067

4.  Etiologic diagnosis of chronic osteomyelitis: a prospective study.

Authors:  Andres F Zuluaga; Wilson Galvis; Juan G Saldarriaga; Maria Agudelo; Beatriz E Salazar; Omar Vesga
Journal:  Arch Intern Med       Date:  2006-01-09

5.  Nontuberculous pyogenic spinal infection in adults: a 12-year experience from a tertiary referral center.

Authors:  Joseph S Butler; Martin J Shelly; Marcus Timlin; William G Powderly; John M O'Byrne
Journal:  Spine (Phila Pa 1976)       Date:  2006-11-01       Impact factor: 3.468

6.  Management of infection associated with total hip arthroplasty according to a treatment algorithm.

Authors:  S G Giulieri; P Graber; P E Ochsner; W Zimmerli
Journal:  Infection       Date:  2004-08       Impact factor: 3.553

7.  Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience.

Authors:  G L Pavoni; M Giannella; M Falcone; L Scorzolini; M Liberatore; B Carlesimo; P Serra; M Venditti
Journal:  Clin Microbiol Infect       Date:  2004-09       Impact factor: 8.067

Review 8.  Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment.

Authors:  A R Berendt; E J G Peters; K Bakker; J M Embil; M Eneroth; R J Hinchliffe; W J Jeffcoate; B A Lipsky; E Senneville; J Teh; G D Valk
Journal:  Diabetes Metab Res Rev       Date:  2008 May-Jun       Impact factor: 4.876

9.  Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis.

Authors:  Heikki Peltola; Markus Pääkkönen; Pentti Kallio; Markku J T Kallio
Journal:  Clin Infect Dis       Date:  2009-05-01       Impact factor: 9.079

10.  [Treatment of osteoarticular infections with clindamycin in adults].

Authors:  Y El Samad; E Havet; H Bentayeb; B Olory; B Canarelli; J-F Lardanchet; Y Douadi; F Rousseau; F-X Lescure; P Mertl; F Eb; J-L Schmit
Journal:  Med Mal Infect       Date:  2008-08-20       Impact factor: 2.152

View more
  8 in total

Review 1.  Antimicrobial stewardship policy: time to revisit the strategy?

Authors:  P-M Roger; J Courjon; S Léotard; C Déchamp; N Négrin; M Vassallo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-19       Impact factor: 3.267

Review 2.  Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.

Authors:  Yvonne Achermann; Ellie J C Goldstein; Tom Coenye; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 3.  Antibiotic therapy in necrotising external otitis: case series of 32 patients and review of the literature.

Authors:  C Pulcini; P Mahdyoun; E Cua; I Gahide; L Castillo; N Guevara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-19       Impact factor: 3.267

4.  Characteristics and treatment outcomes of 69 cases with early prosthetic joint infections of the hip and knee.

Authors:  Y Achermann; P Stasch; S Preiss; K Lucke; M Vogt
Journal:  Infection       Date:  2014-01-29       Impact factor: 3.553

Review 5.  Bone and joint infections due to anaerobic bacteria: an analysis of 61 cases and review of the literature.

Authors:  G Walter; M Vernier; P O Pinelli; M Million; M Coulange; P Seng; A Stein
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-28       Impact factor: 3.267

6.  Efficacy and safety of clindamycin-based treatment for bone and joint infections: a cohort study.

Authors:  J Courjon; E Demonchy; E Cua; E Bernard; P-M Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-07       Impact factor: 3.267

7.  Orthopaedic device-related infection: current and future interventions for improved prevention and treatment.

Authors:  T Fintan Moriarty; Richard Kuehl; Tom Coenye; Willem-Jan Metsemakers; Mario Morgenstern; Edward M Schwarz; Martijn Riool; Sebastian A J Zaat; Nina Khana; Stephen L Kates; R Geoff Richards
Journal:  EFORT Open Rev       Date:  2017-03-13

8.  An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis.

Authors:  Niina Ahola; Noora Männistö; Minna Veiranto; Matti Karp; Jaana Rich; Alexander Efimov; Jukka Seppälä; Minna Kellomäki
Journal:  Biomatter       Date:  2013-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.